Trademark Search in Canada

BLUE EARTH

View On IC.GC.CA

REGISTERED

on 16 Aug 2024

Last Applicant/ Owned by

BLUE EARTH DIAGNOSTICS LIMITED

Magdalen Centre,The Oxford Science ParkOxford OX4 4GA

Serial Number

2170049 filed on 2^th Dec 2021

Registration Number

TMA1250933 registered on 16^th Aug 2024

Registration expiry Date

2^th Dec 2031

Correspondent Address

ROBIC AGENCE PI S.E.C./ ROBIC IP AGENCY LP

630, boul. René-Lévesque Ouest20e étageMontréal

QUÉBEC

H3B1S6

BLUE EARTH

Trademark usage description

medical services, namely medical testing services, medical care and analysis services relating to patient treatment, medical clinic services, medical Read More

Classification Information

Class [001]
Chemicals for use in molecular imaging; diagnostic chemical agents namely, Positron Emission Tomography (PET) imaging tracers for diagnosing cancer; Positron Emission Tomography (PET) imaging tracers; alpha- and beta-emitting radionuclides for use in radionuclide therapy; radioactive isotopes for scientific research use for the diagnosis of cancer; synthetic amino acids for use in PET imaging and radionuclide therapy; reagents for use in PET imaging and radionuclide therapy; non-medical diagnostic scanning agents for in-vivo use; non-medical chemicals for use in molecular imaging.

Classification kind code

Class [005]
Positron Emission Tomography (PET) imaging tracers for detecting cancer; Positron Emission Tomography (PET) imaging tracers for ingestion or injection into humans and animals for detecting cancer; diagnostic preparations for medical purposes namely, radiopharmaceuticals for use in detecting cancer; therapeutic preparations for medical purposes namely for treating cancer; reagents for use in Positron Emission Tomography (PET) imaging ;diagnostic scanning agents for medical use, namely for detecting cancer; preparations for use in molecular imaging (for medical use); pharmaceutical preparations, namely, radiotherapeutic preparations and radiodiagnostic preparations; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical products; radiopharmaceuticals used in the field of nuclear medicine, intended for medical imaging and therapy.

Classification kind code

Class [042]
Scientific and medical research and product design in relation to Positron Emission Tomography (PET) imaging and radionuclide therapy; medical and scientific research in relation to disease diagnosis and treatment; scientific and medical research in relation to molecular imaging; development of molecular imaging products; development of non-medical molecular imaging services; development of radionuclide therapy products; computer-aided diagnostic imaging services for scientific purposes; development of image processing software for scientific imaging; medical laboratory services; medical and pharmacological research services; scientific consultancy in relation to the aforesaid services.

Classification kind code

Class [044]
Medical services, namely medical testing services, medical care and analysis services relating to patient treatment, medical clinic services, medical diagnostic services, and medical examination services; Positron Emission Tomography (PET) medical imaging services; radionuclide therapy services; medical imaging services; medical services in the diagnosis and treatment of conditions in the body; providing medical consultancy in relation to the aforesaid services; development of medical molecular imaging services.

Classification kind code

Mark Details

Serial Number

2170049

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 256 on 3^rd Jan 2023	Notification of Possible Opposition Sent
Submitted for opposition 210 on 22^nd Sept 2022	IR Correction
Submitted for opposition 257 on 22^nd Sept 2022	Designation Notification - Madrid Protocol
Submitted for opposition 210 on 26^th May 2022	IR Correction
Submitted for opposition 257 on 26^th May 2022	Designation Notification - Madrid Protocol
Submitted for opposition 257 on 3^rd Mar 2022	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 2^th Mar 2022	Created
Submitted for opposition 31 on 2^th Mar 2022	Formalized
Submitted for opposition 30 on 2^th Dec 2021	Filed
Submitted for opposition 228 on 2^th Dec 2021	International Registration